ALUMIS INC.

ALMS · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $3.1B · 224 employees
42
SEC Filings
$20.33
Close 2026-06-01
224
Employees

Business Summary

PARTI Overview Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Our name, Alumis, captures our mission to enlighten immunology, and is inspired by the words allumerFrench for illuminateand immunisLatin for the immune system. We are a clinical stage biopharmaceutical company with an initial focus on developing our two Tyrosine Kinase 2 (TYK2) inhibitors: envudeucitinib (envu), formerly known as ESK-001, a second-generation...

Latest Stock Quote

ALMS 2026-06-01 $20.33 O:$21.1 H:$21.6 L:$19.72 Vol:1.6M VWAP:$20.515
origin leaf: d65eff64d6c04c4136894013e1d1681d7e0b3eecc6c19c04c050d66502ce49ae

Next Earnings

Q2 FY2026 — expected 2026-09-06

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001847367-26-000006EDGAR130K words
2025-03-192024-12-310001847367-25-000012EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001847367-25-000050EDGAR88K words
2025-08-132025-06-300001847367-25-000041EDGAR—
2025-05-142025-03-310001847367-25-000028EDGAR—
2024-11-132024-09-300001847367-24-000005EDGAR—
2024-08-132024-06-300001558370-24-012081EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001104659-26-036386EDGAR4K words
2026-03-190001847367-26-000004EDGAR—
2026-01-090001104659-26-002265EDGAR—
2026-01-060001104659-26-001073EDGAR—
2026-01-020001104659-26-000197EDGAR—
2025-11-130001847367-25-000048EDGAR—
2025-09-030001104659-25-086612EDGAR—
2025-08-130001847367-25-000039EDGAR—
2025-08-040001104659-25-073628EDGAR—
2025-05-210001104659-25-051338EDGAR—

42 total filings indexed. 25 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001847367
TickerALMS
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.alumis.com
Listed2024-06-28

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c5dbb2f94e95233ec5eb7e8debbb6c9433e2ba7986e181125e280220cc67cdfb
parent: 2c6a2cd128064fc4ec1a4aa16d4935c22e87bb00b3c6490c5eade34cc8ee182e
content hash: 1a3389017a07d34b33d95d7cef654f98afab1cfbe7138e0d39225afd162a0a27
signed: 2026-06-02T19:00:09.925Z
sources: 8 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf